Embryonics, an Israeli company founded in 2018 in Haifa, has developed an innovative technology called Ubar. Using machine learning algorithms and embryo development data analysis, the system allows the most promising embryos to be selected with high accuracy for transfer to the uterus. This is particularly relevant in IVF programs, including in vitro fertilization with egg donation and IVF with double donation.
Results confirmed by research
According to the developers, Ubar provides a 20% more accurate prediction of successful implantation compared to the results of a group of experienced embryologists. This has been confirmed by several comparative studies. Moreover, the technology is 30% more effective in identifying embryos with low implantation potential.
All this significantly reduces the number of failed IVF attempts and, as a result, reduces financial costs and emotional stress for patients.
How Ubar works
The technology is based on the analysis of data from tens of thousands of IVF cycles, including frame-by-frame video recordings of embryo development. The system evaluates each stage of embryo growth, recording the slightest deviations that may indicate its viability. In addition, the technology is used to select eggs suitable for freezing and further use in delayed motherhood programs, including IVF with egg donation.
Expert opinion
According to Dr. Yael Zamir, CEO of Embryonics, Ubar technology does not attempt to replace specialists, but serves to increase accuracy and objectivity in embryo selection. Based on clinical trials involving patients, the company expects that the use of Ubar will increase the overall success rate of IVF by at least 10%.
The future of artificial intelligence in ART
Embryonics is actively continuing to develop new AI-based solutions to improve the effectiveness of assisted reproductive technologies.
The use of AI and big data analysis opens up opportunities for the creation of new methods for diagnosing and personalizing infertility treatment. This approach helps improve every stage of the procedure, from fertilization to implantation, including complex IVF cases with double donation.
Monitoring that reduces stress
The company also plans to use Ubar for continuous monitoring of embryo development at all stages. This will not only increase the chances of successful implantation, but also reduce the emotional and financial stress associated with failed cycles. Patients will receive clearer guidelines and recommendations from their treating specialists.
The future lies in innovation
Artificial intelligence technologies such as Ubar are becoming an important tool in the reproductive medicine arsenal. They can significantly improve the quality of embryo selection, increase the predictability of outcomes, and make the IVF process more efficient and accessible. These advances open up new possibilities for thousands of families who dream of having a child and are considering IVF programs, including egg donation IVF and double donor IVF.
